BIOCOM PAC sponsored by BIOCOM San Diego
A - OTH
$131.5K
Total received
134
Donations
78
Unique contributors
$981.299
Avg donation
Years active: 2010, 2009
Top Contributions
| Date | Contributor | Type | Amount |
|---|---|---|---|
| Jun 12, 2009 | Arena Pharmaceuticals | OTH | $6,000 |
| Sep 21, 2009 | Invitrogen | OTH | $6,000 |
| Feb 27, 2009 | Genentech | OTH | $6,000 |
| Jan 7, 2010 | Life Technologies | OTH | $6,000 |
| Sep 21, 2009 | Invitrogen | OTH | $6,000 |
| Jan 12, 2010 | Arena Pharmaceuticals | OTH | $6,000 |
| Apr 19, 2010 | Genentech | OTH | $6,000 |
| Sep 21, 2009 | Invitrogen | OTH | $6,000 |
| Nov 10, 2009 | Amgen USA | OTH | $4,000 |
| Nov 10, 2009 | Amgen USA | OTH | $4,000 |
| Apr 6, 2009 | Gen-Probe, Inc. | OTH | $4,000 |
| Jul 28, 2010 | Gen-Probe, Inc. | OTH | $4,000 |
| Nov 10, 2009 | Amgen USA | OTH | $4,000 |
| Apr 27, 2010 | Amgen USA | OTH | $3,000 |
| May 6, 2010 | Pfizer, Inc. | OTH | $3,000 |
| Aug 30, 2010 | Amylin Pharmaceuticals | OTH | $2,500 |
| May 12, 2009 | Pfizer | OTH | $2,500 |
| Apr 2, 2009 | SDG&E | OTH | $2,500 |
| Jul 26, 2010 | Biogen Idec Pharmaceuticals Corp | OTH | $2,500 |
| Apr 1, 2010 | SDG&E | OTH | $2,500 |
| Sep 14, 2009 | Genentech | OTH | $2,125 |
| Sep 14, 2009 | Genentech | OTH | $2,125 |
| Sep 14, 2009 | Genentech | OTH | $2,125 |
| Sep 10, 2009 | Johnson & Johnson Services Inc. | OTH | $1,570 |
| Sep 10, 2009 | Johnson & Johnson Services Inc. | OTH | $1,570 |
| Sep 10, 2009 | Johnson & Johnson Services Inc. | OTH | $1,570 |
| Apr 22, 2009 | Celgene Corporation, Signal Research Division | OTH | $1,500 |
| Mar 23, 2009 | Sequel Pharmaceuticals | OTH | $1,000 |
| Mar 25, 2009 | Signal Pharmaceuticals, LLC, A subsidiary of Celgene Corp | OTH | $1,000 |
| Mar 22, 2010 | Nuvasive, Inc. | OTH | $995 |
| Apr 5, 2010 | Biogen Idec Pharmaceuticals Corp | OTH | $995 |
| May 11, 2009 | Bristol-Myers Squibb | OTH | $995 |
| Oct 29, 2010 | Novartis Pharmaceuticals Corp. | OTH | $785 |
| Sep 14, 2009 | Quidel Corporation | OTH | $785 |
| Feb 9, 2010 | Vical, Inc. | OTH | $785 |
| Sep 14, 2009 | Quidel Corporation | OTH | $785 |
| Sep 14, 2009 | Quidel Corporation | OTH | $785 |
| Jun 1, 2010 | Amylin Pharmaceuticals | OTH | $605 |
| May 20, 2009 | Alphatec Spine, Inc. | OTH | $605 |
| Dec 1, 2010 | CareFusion | OTH | $605 |
| May 5, 2010 | Alphatec Spine, Inc. | OTH | $605 |
| Feb 9, 2010 | Gentoptix, Inc. | OTH | $500 |
| Jan 27, 2009 | Gentoptix, Inc. | OTH | $500 |
| Aug 20, 2009 | Roth, Theodore DRoth Capital Partners | IND | $500 |
| Aug 20, 2009 | Roth, Theodore DRoth Capital Partners | IND | $500 |
| Aug 20, 2009 | Roth, Theodore DRoth Capital Partners | IND | $500 |
| Jun 10, 2009 | ResMed | OTH | $485 |
| Dec 9, 2009 | XOMA, LLC | OTH | $485 |
| Jan 30, 2009 | Sequenom | OTH | $485 |
| Jan 22, 2009 | Vertex Pharmaceuticals | OTH | $485 |
| Dec 9, 2009 | XOMA, LLC | OTH | $485 |
| Dec 9, 2009 | XOMA, LLC | OTH | $485 |
| Nov 2, 2009 | K&L Gates, LLP | OTH | $395 |
| Apr 28, 2009 | CORT Business Services Corporation | OTH | $395 |
| Nov 2, 2009 | K&L Gates, LLP | OTH | $395 |
| Jul 19, 2010 | K&L Gates, LLP | OTH | $395 |
| Nov 2, 2009 | K&L Gates, LLP | OTH | $395 |
| Dec 6, 2010 | Biocept | OTH | $320 |
| Aug 26, 2010 | Synthetic Genomics, Inc. | OTH | $320 |
| Jul 21, 2010 | Optimer Pharmaceuticals, Inc. | OTH | $320 |
| Apr 17, 2009 | SAFC Carlsbad Inc | OTH | $320 |
| Sep 24, 2009 | Sequel Pharmaceuticals | OTH | $270 |
| Sep 24, 2009 | Sequel Pharmaceuticals | OTH | $270 |
| Sep 24, 2009 | Sequel Pharmaceuticals | OTH | $270 |
| Mar 18, 2010 | Conatus Pharmaceuticals Inc. | OTH | $265 |
| Mar 10, 2009 | Roche Diagnostics Corporation | OTH | $265 |
| Mar 30, 2010 | Roth Capital Partners | OTH | $250 |
| Jun 25, 2009 | Genzyme | OTH | $240 |
| Sep 13, 2010 | Fate Therapeutics, Inc. | OTH | $240 |
| Jul 1, 2010 | Genzyme | OTH | $240 |
| Aug 5, 2010 | Naviscan, Inc. | OTH | $240 |
| Jul 19, 2010 | Ligand Pharmaceuticals | OTH | $240 |
| Jul 8, 2010 | Vet-Stem, Inc. | OTH | $240 |
| Apr 20, 2009 | Icx GhC Technologies, Inc. | OTH | $240 |
| Nov 30, 2009 | Veralliance Properties Inc. | OTH | $180 |
| Aug 12, 2009 | Portford Solutions Group, Inc. | OTH | $180 |
| Feb 20, 2009 | Bench International | OTH | $180 |
| Dec 14, 2009 | Phillips Plastics Corporation | OTH | $180 |
| Nov 30, 2009 | Veralliance Properties Inc. | OTH | $180 |
| Sep 15, 2009 | Collins Development Company | OTH | $180 |
| Mar 3, 2009 | DPR Construction, Inc. | OTH | $180 |
| Dec 14, 2009 | Phillips Plastics Corporation | OTH | $180 |
| Sep 15, 2009 | Collins Development Company | OTH | $180 |
| Nov 18, 2009 | Prudential Overall Supply | OTH | $180 |
| Oct 28, 2010 | ICON pic | OTH | $180 |
| Jan 5, 2009 | RoseRyan, Inc. | OTH | $180 |
| May 6, 2009 | Technical Safety Services, Inc. | OTH | $180 |
| Jun 7, 2010 | Campbell Alliance | OTH | $180 |
| Feb 5, 2010 | Sughrue Mion PLLC | OTH | $180 |
| Aug 12, 2009 | Portford Solutions Group, Inc. | OTH | $180 |
| Feb 20, 2009 | Sharp Business Systems | OTH | $180 |
| Mar 9, 2010 | Russo Partners LLC | OTH | $180 |
| Jun 16, 2009 | United Parcel Service | OTH | $180 |
| Dec 14, 2009 | Phillips Plastics Corporation | OTH | $180 |
| Dec 1, 2010 | Collins Development Company | OTH | $180 |
| Jun 5, 2009 | McDermott, Will & Emery | OTH | $180 |
| Jan 11, 2010 | Biomed Realty, LP | OTH | $180 |
| Sep 15, 2009 | Collins Development Company | OTH | $180 |
| Apr 30, 2010 | Perkins Coie | OTH | $180 |
| Aug 12, 2009 | Portford Solutions Group, Inc. | OTH | $180 |
| Nov 18, 2009 | Prudential Overall Supply | OTH | $180 |
| Jul 19, 2010 | DPR Construction, Inc. | OTH | $180 |
| Nov 18, 2009 | Prudential Overall Supply | OTH | $180 |
| Jul 20, 2010 | Aubrey Group | OTH | $180 |
| Apr 21, 2010 | Oxford Finance Corporation | OTH | $180 |
| Nov 30, 2009 | Veralliance Properties Inc. | OTH | $180 |
| Jul 19, 2010 | Prudential Overall Supply | OTH | $180 |
| Nov 3, 2010 | Beckloff Associates | OTH | $180 |
| Dec 7, 2010 | Q5 Group, Inc. | OTH | $180 |
| Oct 11, 2010 | IMS Health | OTH | $180 |
| Aug 6, 2010 | CONNECT | OTH | $150 |
| Jul 19, 2010 | Astute Medical Incorporated | OTH | $120 |
| Oct 27, 2009 | Helicon Therapeutics, Inc. | OTH | $120 |
| Aug 31, 2009 | Tragara Pharmaceuticals, Inc. | OTH | $120 |
| Nov 2, 2009 | Calmune Corporation | OTH | $120 |
| Sep 17, 2009 | Fate Therapeutics, Inc. | OTH | $120 |
| Apr 21, 2010 | Biomatrica, Inc. | OTH | $120 |
| Feb 2, 2010 | InVivoScribe Technologies, LLC | OTH | $120 |
| Feb 1, 2010 | SoluLink Biosciences | OTH | $120 |
| Nov 2, 2009 | Calmune Corporation | OTH | $120 |
| Sep 17, 2009 | Fate Therapeutics, Inc. | OTH | $120 |
| Oct 27, 2009 | Helicon Therapeutics, Inc. | OTH | $120 |
| Nov 2, 2009 | Calmune Corporation | OTH | $120 |
| Sep 17, 2009 | Fate Therapeutics, Inc. | OTH | $120 |
| Oct 27, 2009 | Helicon Therapeutics, Inc. | OTH | $120 |
| Aug 31, 2009 | Tragara Pharmaceuticals, Inc. | OTH | $120 |
| Mar 12, 2009 | Anaphore, Inc. | OTH | $120 |
| Aug 31, 2009 | Tragara Pharmaceuticals, Inc. | OTH | $120 |
| Jul 29, 2010 | Johnson & Johnson Services Inc. | OTH | $100 |
| Dec 29, 2009 | Gable PR | OTH | $100 |
| Dec 29, 2009 | Gable PR | OTH | $100 |
| Dec 29, 2009 | Gable PR | OTH | $100 |
| Nov 3, 2010 | Zogenix | OTH | $60 |
| Aug 31, 2010 | Biocom San Diego | OTH | $14 |